Amgen

Amgen discovers, develops, manufactures and delivers human therapeutics for patients suffering from serious illnesses. Read more

73,079 Followers on Owler
73,079 Followers on Owler
73,079 Followers on Owler
73,079 Followers on Owler

Amgen

Amgen discovers, develops, manufactures and delivers human therapeutics for patients suffering from serious illnesses. Read more

Robert A. Bradway's photo - Chairman & CEO of Amgen

Chairman & CEO

Robert A. Bradway

CEO Approval Rating

72/100

Founded:

1980

Status:

PublicIndependent CompanyNASDAQAMGN

AMGEN TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

AbbVie is the top competitor of Amgen. AbbVie was founded in 2013, and its headquarters is in North Chicago, Illinois. AbbVie is in the Pharmaceuticals field. AbbVie has 27,800 more employees than Amgen.

Celgene is seen as one of Amgen's top competitors. Celgene was founded in Summit, New Jersey} in 1986. Like Amgen, Celgene also works within the Biotechnology industry. Compared to Amgen, Celgene generates $11.1B less revenue.

Coherus BioSciences is Amgen's #3 rival. Coherus BioSciences's headquarters is in Redwood City, California, and was founded in 2010. Like Amgen, Coherus BioSciences also competes in the Biotechnology sector. Coherus BioSciences generates 1.70% of Amgen's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Mylan a competitor of Amgen?

Amgen Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$26.3B

Amgen's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 25.9B. Over the last four quarters, Amgen's revenue has decreased by 4.9%. Specifically, in Q1 2021's revenue was $5.9B; in Q4 2020, it was $7.8B; in Q3 2020, it was $6.4B; in Q2 2020, Amgen's revenue was $6.2B.

Amgen Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Rodeo Therapeutics Corporation

Mar 2021

Source »
$55M
Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases.
Five Prime Therapeutics, Inc.

Mar 2021

Source »
$1.9B
Five Prime is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of gastric cancer.
Nuevolution A/S

May 2019

Source »
$166.8M
Nuevolution develops small molecule drug therapeutics for the treatment of cancer and chronic inflammatory diseases.

-

Catherex, Inc

Dec 2015

Source »
$10.5M
-
Dezima Pharma BV

Sep 2015

Source »
$300M
Dezima Pharma is engaged in the development of novel drugs to treat cardiovascular disease related to dyslipidemia.

These are all the companies that Amgen has acquired. Amgen has acquired 21 companies and its latest acquisition was Rodeo Therapeutics Corporation in Mar 2021. Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases.

Amgen Funding History

Since Amgen was founded in 1980, it has participated in 2 rounds of funding. In total Amgen has raised $4.0B. Amgen's last funding round was on Feb 2020 for a total of $4.0B

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Feb 2020
$4B
-
Debt
Apr 1980
$19M
-

Since Amgen was founded in 1980, it has participated in 2 rounds of funding. In total Amgen has raised $4.0B. Amgen's last funding round was on Feb 2020 for a total of $4.0B

Amgen Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Carmot is a biotechnology company that researches and commercializes novel therapeutics for patients with cancer and metabolic disorders.
$47M
Sep 16, 2020
Series C
-
Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard for parents and teachers.
$3M
Jul 20, 2020
Grant
-
GNS is an AI-based platform that offers drug modeling and intervention optimization solutions for the healthcare industry.
$5M
Jan 06, 2020
Series D
-
Oxford Nanopore is a UK-based biotechnology company that provides gene analysis, nanopore DNA sequencing, IVD testing and related solutions for medical research centers.
$66M
Oct 17, 2018
Equity
-
Science 37 develops a virtual clinical trial management platform that provides eSource and patient engagement solutions for the healthcare sector.
$130M
Jun 06, 2018
Series D
-

These are all the companies that Amgen has invested in. Amgen has invested 21 companies and its latest investment was Rodeo Therapeutics Corporation in Mar 2021. Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases.

Amgen News

May 11, 2021MarketScreener

Collaboration to Improve Bone Health Education Published in Cancer Management and Research

(marketscreener.com) Rochester, NY, May 11, 2021 -- GRYT Health, a digital oncology company that empo... See more »
May 9, 2021BioPharma Dive

Amgen asks FDA for approval of key asthma drug

Tezepelumab is one of Amgen's top experimental medicines and a U.S. OK would help its efforts to offs... See more »
May 7, 2021San Fernando Valley Business Journal

Amgen Adopts Permanent Remote Work Policy

Newbury Park-based pharmaceuticals company Amgen will make working from home a permanent policy for m... See more »
May 7, 2021CompanyNews HQ

Amgen To Present At The 2021 Bank of America Merrill Lynch Healthcare Conference

THOUSAND OAKS, Calif., May 6, 2021 /PRNewswire/ - Amgen (NASDAQ:AMGN) will present at the 2021 Bank o... See more »
May 4, 2021The Center for Biosimilar

Amgen Canada Launches Adalimumab Biosimilar

Amgevita is now broadly available across Canada.... See more »
May 3, 2021Contract Pharma

CCRM and Amgen Partner to Advance Emerging Medical Innovations

New fund to support regenerative medicine discoveries with high potential impact for patients.... See more »
April 30, 2021The Center for Biosimilar

Amgen, Merck, Teva Provide First-Quarter Biosimilars Info

There's no end in sight for Enbrel (etanercept) sales erosion, but Amgen's biosimilars are holding th... See more »

Amgen Press Releases

March 3, 2021PR Newswire

Amgen Announces 2021 Second Quarter Dividend

THOUSAND OAKS, Calif., March 3, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Boa... See more »
February 22, 2021PR Newswire

Amgen To Webcast Investor Meeting At AAAAI Virtual Annual Meeting

THOUSAND OAKS, Calif., Feb. 22, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for... See more »
February 16, 2021PR Newswire

FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

THOUSAND OAKS, Calif., Feb. 16, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S... See more »
February 9, 2021PR Newswire

Amgen To Present At Guggenheim Healthcare Talks Oncology Day

THOUSAND OAKS, Calif., Feb. 9, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that Greg Fri... See more »
January 26, 2021PR Newswire

Amgen To Webcast Investor Meeting At 2020 World Conference on Lung Cancer

THOUSAND OAKS, Calif., Jan. 26, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for... See more »
January 26, 2021Business Wire

Macedonia Community Development Corporation Receives $150,000 From the Amgen Foundation to Support Business Accelerator Program

LOS ANGELES--(BUSINESS WIRE)--Macedonia Community Development Corporation (Macedonia CDC) today annou... See more »

Amgen Videos

Social Media

Amgen Headquarters

One Amgen Center Drive

Thousand Oaks, California91320

805-447-1000

Driving Directions »

Trending Companies

Amgen Summary

ABOUT

Overview

Amgen discovers, develops, manufactures and delivers human therapeutics for patients suffering from serious illnesses. Amgen was founded in 1980. Amgen's headquarters is located in Thousand Oaks, California, USA 91320. It has raised 4.0B in 2 rounds. ...

CEO

Amgen's Chairman & CEO, Robert A. Bradway, currently has an approval rating of 72%. Amgen's primary competitors are AbbVie, Celgene & Coherus BioSciences.

Website

amgen.com

Frequently Asked Questions about Amgen

  1. When was Amgen founded?

    Amgen was founded in 1980
  2. Who is Amgen's CEO?

    Amgen's CEO is Robert A. Bradway
  3. How much revenue does Amgen generate?

    Amgen generates $26.3B in revenue
  4. How much funding does Amgen have?

    Amgen has historically raised $4B in funding
  5. Where is Amgen's headquarters?

    Amgen's headquarters is in Thousand Oaks California, USA
  1. How many employees does Amgen have?

    Amgen has 19,200 employees
  2. What sector does Amgen operate in?

    Amgen is in Biotechnology
  3. Who are Amgen's competitors?

    Amgen's top competitors are AbbVie, Celgene, Coherus BioSciences
  4. Who has Amgen invested in?

    Amgen's has invested in companies such as Carmot, Khan Academy, GNS Healthcare